Vitiligo during dupilumab therapy
Uložené v:
| Vydané v: | JAAD Case Reports Ročník 36; s. 51 - 53 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Elsevier Inc
01.06.2023
Elsevier |
| Predmet: | |
| ISSN: | 2352-5126, 2352-5126 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Author | Torta, Ginevra Napolitano, Maddalena Fabbrocini, Gabriella Picone, Vincenzo Patruno, Cataldo |
|---|---|
| Author_xml | – sequence: 1 givenname: Vincenzo surname: Picone fullname: Picone, Vincenzo email: vince.picone95@gmail.com organization: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy – sequence: 2 givenname: Maddalena surname: Napolitano fullname: Napolitano, Maddalena organization: Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy – sequence: 3 givenname: Ginevra surname: Torta fullname: Torta, Ginevra organization: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy – sequence: 4 givenname: Gabriella surname: Fabbrocini fullname: Fabbrocini, Gabriella organization: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy – sequence: 5 givenname: Cataldo surname: Patruno fullname: Patruno, Cataldo organization: Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37250007$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkt9rFDEQx4NUbD37D_gg9c2Xu-b37oooUtQWCn3wx2vIJbPXWXOba7JbuP_erNeWtmCFwITJ9_uZMDMvyV4feyDkNaMLRpk-7hadd2nBKRcLWg5Xz8gBF4rPFeN67959nxzm3FFKmZKVqNgLsi8qrkqiOiBvf-GAAVfxyI8J-1UJGwzj2i6PhktIdrN9RZ63NmQ4vIkz8vPrlx8np_Pzi29nJ5_P505JoeaaV55V1lW1oFYqUMDrRqjalqKq0cJWrdfSeQBwNV0C861TXAuhQdmagZiRsx3XR9uZTcK1TVsTLZq_iZhWxqYBXQCjaqeUbZvClFJ6Z0Wz5LbxWrWOygKdkU871mZcrsE76IdkwwPow5ceL80qXhtGOW20rAvh3Q0hxasR8mDWmB2EYHuIYza8noRaKlakb-4Xu6ty2-Qi4DuBSzHnBO2dhFEzDdN0ZhqmmYZpaDlcFVP9yORwsAPG6cMYnrZ-2FmhjOsaIZnsEHoHHhO4ofQTn7Z_fGR3AXt0NvyGLeQujqkvi2CYydxQ831atGnPuCgrxitRAO__Dfhf9T9c9-Da |
| CitedBy_id | crossref_primary_10_1016_j_jdcr_2025_05_045 crossref_primary_10_4081_dr_2023_9839 crossref_primary_10_1016_j_jdcr_2025_05_048 crossref_primary_10_1080_1744666X_2025_2512452 crossref_primary_10_1093_bjd_ljae266_108 crossref_primary_10_1111_ajd_14557 crossref_primary_10_1111_jdv_20279 crossref_primary_10_1111_jdv_20411 crossref_primary_10_2147_CCID_S488354 crossref_primary_10_1016_j_jdcr_2023_09_006 crossref_primary_10_1111_ajd_14353 crossref_primary_10_3389_fimmu_2024_1455050 crossref_primary_10_3389_fimmu_2024_1405215 crossref_primary_10_1016_j_jaci_2025_04_016 crossref_primary_10_1016_j_jaci_2025_06_002 crossref_primary_10_1111_1346_8138_17698 crossref_primary_10_1111_cea_14583 |
| Cites_doi | 10.1111/dth.15324 10.1111/jocd.12517 10.1111/dth.15588 10.2340/actadv.v101.545 10.1016/j.jaad.2020.08.051 10.1146/annurev-immunol-100919-023531 |
| ContentType | Journal Article |
| Copyright | 2023 American Academy of Dermatology, Inc. American Academy of Dermatology, Inc. 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2023 American Academy of Dermatology, Inc. |
| Copyright_xml | – notice: 2023 American Academy of Dermatology, Inc. – notice: American Academy of Dermatology, Inc. – notice: 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2023 American Academy of Dermatology, Inc. |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.jdcr.2023.03.025 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Open Access: DOAJ - Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2352-5126 |
| EndPage | 53 |
| ExternalDocumentID | oai_doaj_org_article_58c55af9a7f444dca39b2a9d65fc0426 PMC10209648 37250007 10_1016_j_jdcr_2023_03_025 S2352512623001273 1_s2_0_S2352512623001273 |
| Genre | Case Reports |
| GroupedDBID | .1- .FO 0R~ 1P~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV EBS EJD FDB GROUPED_DOAJ HYE IPNFZ IXB KQ8 M41 M~E O9- OK1 RIG ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ ABMYL AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c5435-627d17ac7830a45e5e289358a5475963a7fd64cdeeec80be1dfc526336e5a81e3 |
| IEDL.DBID | DOA |
| ISSN | 2352-5126 |
| IngestDate | Fri Oct 03 12:48:47 EDT 2025 Thu Aug 21 18:37:39 EDT 2025 Thu Sep 04 16:53:37 EDT 2025 Mon Jul 21 05:43:19 EDT 2025 Thu Nov 13 04:24:27 EST 2025 Tue Nov 18 22:30:32 EST 2025 Sat Mar 16 16:14:11 EDT 2024 Tue Feb 25 20:12:41 EST 2025 Tue Aug 26 16:32:00 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | vitiligo atopic dermatitis dupilumab |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5435-627d17ac7830a45e5e289358a5475963a7fd64cdeeec80be1dfc526336e5a81e3 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 Author is deceased. |
| OpenAccessLink | https://doaj.org/article/58c55af9a7f444dca39b2a9d65fc0426 |
| PMID | 37250007 |
| PQID | 2820966451 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_58c55af9a7f444dca39b2a9d65fc0426 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10209648 proquest_miscellaneous_2820966451 pubmed_primary_37250007 crossref_primary_10_1016_j_jdcr_2023_03_025 crossref_citationtrail_10_1016_j_jdcr_2023_03_025 elsevier_sciencedirect_doi_10_1016_j_jdcr_2023_03_025 elsevier_clinicalkeyesjournals_1_s2_0_S2352512623001273 elsevier_clinicalkey_doi_10_1016_j_jdcr_2023_03_025 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-06-01 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAAD Case Reports |
| PublicationTitleAlternate | JAAD Case Rep |
| PublicationYear | 2023 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Napolitano, Nocerino, Picone (bib3) 2022; 35 Napolitano, Fabbrocini, Potestio (bib1) 2022; 35 Aschenbrenner (bib4) 2023; 123 Takeoka, Kamata, Yokoi, Takehara, Tada (bib5) 2021; 101 Sushama, Dixit, Gautam, Arora, Khurana, Anubhuti (bib6) 2019; 18 Frisoli, Essien, Harris (bib7) 2020; 38 Halling, Loft, Silverberg, Guttman-Yassky, Thyssen (bib2) 2021; 84 Halling (10.1016/j.jdcr.2023.03.025_bib2) 2021; 84 Napolitano (10.1016/j.jdcr.2023.03.025_bib1) 2022; 35 Takeoka (10.1016/j.jdcr.2023.03.025_bib5) 2021; 101 Frisoli (10.1016/j.jdcr.2023.03.025_bib7) 2020; 38 Sushama (10.1016/j.jdcr.2023.03.025_bib6) 2019; 18 Aschenbrenner (10.1016/j.jdcr.2023.03.025_bib4) 2023; 123 Napolitano (10.1016/j.jdcr.2023.03.025_bib3) 2022; 35 |
| References_xml | – volume: 38 start-page: 621 year: 2020 end-page: 648 ident: bib7 article-title: Vitiligo: mechanisms of pathogenesis and treatment publication-title: Annu Rev Immunol – volume: 35 year: 2022 ident: bib3 article-title: Dupilumab for the treatment of atopic dermatitis in transplant patients: two case reports and literature review publication-title: Dermatol Ther – volume: 84 start-page: 139 year: 2021 end-page: 147 ident: bib2 article-title: Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis publication-title: J Am Acad Dermatol – volume: 101 year: 2021 ident: bib5 article-title: Rapid enlargement of vitiligo vulgaris after initiation of dupilumab for atopic dermatitis: a case report publication-title: Acta Derm Venereol – volume: 35 year: 2022 ident: bib1 article-title: A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis publication-title: Dermatol Ther – volume: 18 start-page: 337 year: 2019 end-page: 341 ident: bib6 article-title: Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease publication-title: J Cosmet Dermatol – volume: 123 start-page: 26 year: 2023 end-page: 27 ident: bib4 article-title: New dupilumab indication for rare skin disease publication-title: Am J Nurs – volume: 35 issue: 4 year: 2022 ident: 10.1016/j.jdcr.2023.03.025_bib3 article-title: Dupilumab for the treatment of atopic dermatitis in transplant patients: two case reports and literature review publication-title: Dermatol Ther doi: 10.1111/dth.15324 – volume: 18 start-page: 337 issue: 1 year: 2019 ident: 10.1016/j.jdcr.2023.03.025_bib6 article-title: Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-α) in vitiligo-New insight into pathogenesis of disease publication-title: J Cosmet Dermatol doi: 10.1111/jocd.12517 – volume: 123 start-page: 26 issue: 2 year: 2023 ident: 10.1016/j.jdcr.2023.03.025_bib4 article-title: New dupilumab indication for rare skin disease publication-title: Am J Nurs – volume: 35 issue: 8 year: 2022 ident: 10.1016/j.jdcr.2023.03.025_bib1 article-title: A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis publication-title: Dermatol Ther doi: 10.1111/dth.15588 – volume: 101 issue: 10 year: 2021 ident: 10.1016/j.jdcr.2023.03.025_bib5 article-title: Rapid enlargement of vitiligo vulgaris after initiation of dupilumab for atopic dermatitis: a case report publication-title: Acta Derm Venereol doi: 10.2340/actadv.v101.545 – volume: 84 start-page: 139 issue: 1 year: 2021 ident: 10.1016/j.jdcr.2023.03.025_bib2 article-title: Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2020.08.051 – volume: 38 start-page: 621 year: 2020 ident: 10.1016/j.jdcr.2023.03.025_bib7 article-title: Vitiligo: mechanisms of pathogenesis and treatment publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-100919-023531 |
| SSID | ssj0001547371 |
| Score | 2.3457973 |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 51 |
| SubjectTerms | atopic dermatitis Case Report Dermatology dupilumab vitiligo |
| Title | Vitiligo during dupilumab therapy |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2352512623001273 https://www.clinicalkey.es/playcontent/1-s2.0-S2352512623001273 https://dx.doi.org/10.1016/j.jdcr.2023.03.025 https://www.ncbi.nlm.nih.gov/pubmed/37250007 https://www.proquest.com/docview/2820966451 https://pubmed.ncbi.nlm.nih.gov/PMC10209648 https://doaj.org/article/58c55af9a7f444dca39b2a9d65fc0426 |
| Volume | 36 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9RAFD5oEfFFvBsvZQu-STCZ-zyqtPjSInhh34bJzERTSrY0W8EXf7vnZJJlV6V9EZYs7GYS8uWbOd9hzgXglamYbQWFSqG1LkWqRWkbycsgE0d-iGhjMzab0CcnZrm0H7dafVFMWC4PnIF7I02Q0rfW61YIEYPntmHeRiXbQPqfVl9UPVvOVM4PFpqP3hZDhVGiVVNTxkwO7jqNgYqBMj5WOKU-2VtWaSzev2Oc_haff8ZQbhmlo3twd1KTi7f5Ke7DjdQ_gNvH0375Qzj42q27s-7bapHTEfHrvMPlyDeLnHj18xF8OTr8_P5DOTVFQPhQ2pSK6VhrH7ThlRcyyYQuE5fGS6rcpzjiFJUIMaUUTNWkOrZBMsW5StKbOvHHsNev-vQUFrEJ3vuae2OS8CY1XiodbOONDLz2toB6BsWFqWI4Na44c3No2KkjIB0B6Sr8MFnA682Y81wv48qz3xHWmzOp1vX4AzLATQxw1zGgAD6_KTenk-ICiBfqrry1_teoNExzeHC1G5ir3CdiEBEInTXap-cFyM3ISaZk-XHtHQ9mGjmcw7Qx4_u0uhwcur3oSSoh6wKeZFptIOGaUc8KXYDZIdwOZrv_9N33sU44ake8rDDP_gfKz-EOPUuOknsBe-uLy_QSboUf62642Iebemn2xzmIx-Nfh78BpQUzMw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vitiligo+during+dupilumab+therapy&rft.jtitle=JAAD+Case+Reports&rft.au=Picone%2C+Vincenzo%2C+MD&rft.au=Napolitano%2C+Maddalena%2C+MD&rft.au=Torta%2C+Ginevra%2C+MD&rft.au=Fabbrocini%2C+Gabriella%2C+MD%2C+PhD&rft.date=2023-06-01&rft.issn=2352-5126&rft.eissn=2352-5126&rft.volume=36&rft.spage=51&rft.epage=53&rft_id=info:doi/10.1016%2Fj.jdcr.2023.03.025&rft.externalDBID=ECK1-s2.0-S2352512623001273&rft.externalDocID=1_s2_0_S2352512623001273 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F23525126%2FS2352512623X00058%2Fcov150h.gif |